Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Ayisha Jeter

Arcutis Biotherapeutics, Inc. reported in an 8-K filed May 24, 2023 that Ayisha Jeter was appointed interim chief commercial officer.

“The Company has commenced a search for a permanent chief commercial officer and has appointed Ayisha Jeter, who has served as the Company's Vice President of Market Access since joining the Company in June 2020, as interim chief commercial officer during the transition period.”
Arcutis Biotherapeutics, Inc. Form 8-K, filed May 24, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Arcutis Biotherapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.